Artra Group (TSE:6029) Marketable Securities: 円0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6029 Artra Group Corp TSE:6029
57 GF Score
Price 円189.00
GF Value 円116.25
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Artra Group Marketable Securities?

Artra Group TSE:6029 57 Marketable Securities is 円0 Mil as of Jun. 2026. GuruFocus rates TSE:6029 with a GF Score™ of 57/100 and a GF Value™ of 円116.25 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Artra Group's Marketable Securities for the quarter that ended in Jun. 2026 was 円0 Mil.

Artra Group  (TSE:6029) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Artra Group Marketable Securities Related Terms

Artra Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for Artra Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artra Group Marketable Securities Chart

Artra Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Artra Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:6029
57GF Score
Artra Group Corp TSE:6029
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artra Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円0 Mil mean?
Artra Group (TSE:6029) has a Marketable Securities of 円0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Artra Group and its competitors.
Is Artra Group's Marketable Securities too high?
Artra Group's current Marketable Securities is 円0 Mil. Overall, Artra Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Marketable Securities compare to HCA and THC?
Artra Group's Marketable Securities of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Artra Group and its competitors. Artra Group's current Marketable Securities is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円116.25, compared to a current price of 円189.00 — trading 62.6% above its estimated fair value. The current Marketable Securities is 円0 Mil. Artra Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Marketable Securities is 円0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artra Group (TSE:6029) Overvalued in 2026?

Based on GuruFocus' analysis, Artra Group stock appears to be overvalued. The current stock price of 円189.00 is trading 62.6% above its estimated GF Value™ of 円116.25. GuruFocus considers Artra Group to be Significantly Overvalued.

Key valuation signals for TSE:6029:

  • Marketable Securities: 円0 Mil
  • GF Value™: 円116.25 vs. price of 円189.00 (62.6% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Artra Group Business Description

Address 4-6-9 Tachimichibori, Taiga Building, Nishi-ku, Osaka, JPN, 550-0012
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
57GF Score

Get the complete analysis for TSE:6029

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円189.00
Price
円116.25
GF Value